361-372 of 372
The Elephant in the Room: Health Care in DC
Clinician's RoundtableThe Elephant in the Room: Health Care in DC
Judy Feder, PhD
Paul Raeburn
Lowering the Cost of Pharmaceuticals: What Can Be Done in Washington?
Clinician's RoundtableLowering the Cost of Pharmaceuticals: What Can Be Done in Washington?
Mary Agnes Carey
Paul Raeburn
The Future of SCHIP: How to Insure More Children
Clinician's RoundtableThe Future of SCHIP: How to Insure More Children
Ron Pollack, JD
Paul Raeburn
A Former FDA Commissioner Looks Back at the Agency
Clinician's RoundtableA Former FDA Commissioner Looks Back at the Agency
Donald Kennedy, MD
Paul Raeburn
Anti-Smoking Campaigns: Impact on the movie industry
Clinician's RoundtableAnti-Smoking Campaigns: Impact on the movie industry
Stanton Glantz, MD
Paul Raeburn
Reforming Medicare: Issues and Policy Changes
Clinician's RoundtableReforming Medicare: Issues and Policy Changes
Hoangmai H. Pham, MD
Paul Raeburn
- advertisement
Pay for Performance: Can it Really Work?
Clinician's RoundtablePay for Performance: Can it Really Work?
Hoangmai H. Pham, MD
Paul Raeburn
Updates on Food Labeling: Effects Felt from Manufacturers to Consumers
Clinician's RoundtableUpdates on Food Labeling: Effects Felt from Manufacturers to Consumers
Michael Jacobson, PhD
Paul Raeburn
Allen Anderson, MD
Matthew J. Sorrentino, MD, FACC, FASH
Acute Decompensated Heart Failure:the UNLOAD Trial
Clinician's RoundtableAcute Decompensated Heart Failure:the UNLOAD Trial
Allen Anderson, MD
Matthew J. Sorrentino, MD, FACC, FASH
Decrease In Cancer Funding Nationwide: Impacts on Patients
Clinician's RoundtableDecrease In Cancer Funding Nationwide: Impacts on Patients
Diane Colaizzi
Paul Raeburn
Antibiotics in Cattle: Considerations in the FDA's Approval Process
Clinician's RoundtableAntibiotics in Cattle: Considerations in the FDA's Approval Process
James Leggett, MD
Paul Raeburn
- advertisement